Knee

All-new 2025 INFINITI QX80 reimagines the luxury SUV

Retrieved on: 
Wednesday, March 20, 2024
Retail, Automotive Manufacturing, Manufacturing, Other Automotive, Women, Performance & Special Interest, Luxury, Off-Road Trucks & SUVs, Parenting, Men, General Automotive, Aftermarket, Family, Automotive, Consumer, Vehicle Technology, Knee, Friends, Friction, Light-emitting diode, 4WD, Child, Eye, Classic, USB, System, Cruise control, Elegance, Safety, Access, Torque, Accessibility, Language, Invisible Hood, Hand, Projection, Personal, Snow, Acceleration, Google Maps, Lane departure warning system, Tri-Power, LUXE, Grill, Aluminium, LED, SUV, Engineering, Element, Temperature, Attention, Smartphone, Journey, Heat, Paint, Light, Water, Atmosphere, Lighting, Music, Telescopic sight

The all-new 2025 INFINITI QX80 is the first model to showcase the latest evolution of INFINITI design, building on long-standing expertise in craftsmanship and detailing.

Key Points: 
  • The all-new 2025 INFINITI QX80 is the first model to showcase the latest evolution of INFINITI design, building on long-standing expertise in craftsmanship and detailing.
  • The 2025 INFINITI QX80 is the first vehicle in the full-size luxury SUV segment with Klipsch® premium audio systems, reflecting the priority luxury clients place on highly accurate, lifelike sound for entertainment.
  • Luggage space has increased in the all-new 2025 INFINITI QX80, making it even simpler to bring along all of life’s needs.
  • As the flagship SUV in the INFINITI range, the 2025 QX80 delivers confident, capable performance balanced with refinement.

LuskinOIC Partners with the Center for Cerebral Palsy at UCLA to Host Annual Cerebral Palsy Professional Conference and Family Forum on March 23

Retrieved on: 
Tuesday, March 19, 2024
Family, Health, Consumer, Neurology, Other Health, Children, General Health, Community, Knee, Spasticity, DPT, Cerebral palsy, Conference, Neurotoxin, PCS, Doctor of Philosophy, MD, Functional, Physical disability, CP, Bangladesh Technical Education Board, Active Life: Outdoor Challenge, UCLA, Social

On Saturday, March 23, 2024, LuskinOIC and the Center for Cerebral Palsy at UCLA will offer education for professionals, people with cerebral palsy and family members affected by cerebral palsy.

Key Points: 
  • On Saturday, March 23, 2024, LuskinOIC and the Center for Cerebral Palsy at UCLA will offer education for professionals, people with cerebral palsy and family members affected by cerebral palsy.
  • The conference takes place during National Cerebral Palsy Awareness month.
  • Registration is required for both the Professional Conference Agenda & Registration and Family Forum Agenda & Registration .
  • Symposium sponsors include the Cerebral Palsy Foundation, the Shapiro Family Foundation, and the Tarjan Center.

World’s First Total Knee Replacement Patient Treated with PolarisAR Breakthrough Mixed-Reality Surgical Guidance System

Retrieved on: 
Monday, March 18, 2024
Technology, Medical Devices, Surgery, Hospitals, FDA, Software, Other Health, General Health, Health, Data Management, Stellar, Knee, TKA, Surgeon, Environment, Hospital, Workflow, Medical device

PolarisAR , a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.

Key Points: 
  • PolarisAR , a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.
  • View the full release here: https://www.businesswire.com/news/home/20240318792314/en/
    The world's first total knee arthroplasty (TKA) was performed using the breakthrough STELLAR Knee mixed-reality surgical guidance system from PolarisAR.
  • STELLAR Knee is a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment.
  • The STELLAR Knee system is designed to offer precise control over intraoperative variables compared to traditional instruments, navigation systems, and first-generation augmented reality.

REGENATIVE LABS' LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON'S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

Retrieved on: 
Thursday, April 4, 2024
Knee, MDPI, Stiffness, Shoulder, Safety, Hip, Wharton's jelly, Rotator cuff, Patient, Research, Rehabilitation, Quality of life, Manager, Efficacy, WOMAC, Regenerative medicine, Quality, Literature, Spine, Orthopedic surgery, Pain, Calendar, Physician, Injury, WJ, Medicine, Dentistry

PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.

Key Points: 
  • PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
  • Patients in need of rotator cuff repairs often seek minimally invasive options, making Wharton's Jelly a promising alternative for musculoskeletal defects.
  • Utilizing the structural connective tissue allografts has allowed many patients to avoid surgery altogether and significantly improve their quality of life."
  • The study titled "Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears," was published by MDPI and can be accessed in its entirety here.

Delaware North launches expanded 'Bee the Difference' campaign with two craft cocktails for Earth Month

Retrieved on: 
Monday, April 1, 2024
Empire, Pollination, Bee, Grand Canyon National Park, Environment, Envy, Hartsfield–Jackson Atlanta International Airport, Agriculture, Partnership, Knee, Education, School, Bacardi, Food, Joachim Splichal, World Bee Day, Krazy Kat filmography, Bridgestone Arena, Restaurant, Walt Disney, Airport, Walt Disney World

BUFFALO, N.Y., April 1, 2024 /PRNewswire/ -- Delaware North, a global leader in hospitality and entertainment, today announced the launch on April 1 of "Bee the Difference," its second annual campaign in partnership with The Bee Cause Project to promote education and awareness for our planet's pollinators.

Key Points: 
  • "Delaware North is once again honored to help bring attention to bees, which are critical to our environment and agriculture," said Debbie Friedel, corporate director of sustainability at Delaware North.
  • This year's campaign has been expanded beyond Earth Month and features a second beverage option.
  • Following the 2023 campaign, Delaware North donated over $20,000 to the nonprofit organization.
  • The project offers a variety of grants and resources to schools and nonprofit organizations across North America, Canada and beyond.

Vector Solutions and USCAH Announce Partnership to Strengthen the Health and Safety of Athletes

Retrieved on: 
Tuesday, March 19, 2024
Knee, LMS, MEC, Conference, Education, Pressure, Sport, Learning, Partnership, Risk, K-12, School, Travel, Policy, University, Death, Commotio cordis, Athlete, Student, University of Arizona, MPH, Mountain East Conference, Safety, Injury, Occupational safety and health, Collegiate, Nursing

TAMPA, Fla., March 19, 2024 /PRNewswire-PRWeb/ -- Today, Vector Solutions, the leading provider of training and software solutions dedicated to helping educational institutions make their operations and communities safer, smarter, and better, has announced its partnership with the U.S. Council for Athletes' Health (USCAH) to offer schools and colleges access to nearly 50 health and safety courses that help prevent catastrophic injuries in sports.

Key Points: 
  • Collegiate athletes face unique physical and mental health challenges as they balance intense practices, game days, course loads, and travel requirements.
  • "At Vector Solutions, we want to ensure everyone involved in school-based athletic programs has the information and skills they need to keep athletes safe and supported," said Rob Buelow, General Manager, Education at Vector Solutions.
  • We are also thankful for collaboration with USCAH in utilizing their modules on Health and Safety education for our staff."
  • To learn more about the Vector Solutions and USCAH partnership, click here .

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Retrieved on: 
Monday, March 4, 2024
IIT, Regenerative medicine, Research, Microsoft Exchange Server, News, Ageing, Cancer, GMP, Cartilage, Cell, National University Hospital, SingHealth, SKH, B cell, Safety, UC, Transplant, Knee, Patient, Clinical trial, Osteoarthritis, MSC, Umbilical cord, RCA, Pharmaceutical industry

Osteoarthritis of the knee is a debilitating disease affecting Singapore’s aging population and the clinical trial will pioneer stem cell use for regenerative medicine in Singapore.

Key Points: 
  • Osteoarthritis of the knee is a debilitating disease affecting Singapore’s aging population and the clinical trial will pioneer stem cell use for regenerative medicine in Singapore.
  • UC-MSCs are a type of adult stem cells that can be isolated from the umbilical cord tissue after childbirth.
  • UC-MSCs are considered multipotent and are able to differentiate into different cell types, including bone, cartilage, fat, and muscle cells.
  • "Our collaboration with CytoMed marks a significant step in advancing research on allogeneic in-vivo UC-MSC for cartilage repair, including osteoarthritis of the knee.

Modiv Industrial Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 4, 2024
REIT, Manufacturing, Other Manufacturing, Commercial Building & Real Estate, Construction & Property, CHIPS, Ethos, Air force, YTD, Sale, Tenant, Webcast, Organization, Concussion, Kodak, NFL, Social media, LINK, NBA, CHIPS and Science Act, Pain, Electronics, Pharmacy, Emergency service, Infinite, Motivation, MDV, Nose, Calf, Balance sheet, UFC, Partnership, Life, Fed, Creativity, MLB, Human, Internet, AI, Poultry, Quality of life, Greed, PPV, Thought, Mechanics, Government, Federal Reserve, Risk, Industrial, Real estate investment trust, Painting, Knee, Crutch, Travel, Real estate

Modiv Industrial, Inc. (“Modiv Industrial”, “Modiv”, the “Company”, “we” or “our”) (NYSE:MDV), the only public REIT exclusively focused on acquiring industrial manufacturing real estate, today announced operating results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Modiv Industrial, Inc. (“Modiv Industrial”, “Modiv”, the “Company”, “we” or “our”) (NYSE:MDV), the only public REIT exclusively focused on acquiring industrial manufacturing real estate, today announced operating results for the fourth quarter and full year ended December 31, 2023.
  • Fourth quarter revenue of $12.3 million increased $2.3 million year-over-year, or 23%, excluding the 2022 lease termination fee.
  • Fourth quarter AFFO of $4.5 million, or $0.40 per diluted share, exceeding street expectations by $0.05 per share.
  • January 31, 2024, completed the stock distribution of Generation Income Properties, Inc. (NASDAQ: GIPR), common stock to the stockholders of Modiv Industrial.

PK MED Announces FDA Clearance to Initiate Its Clinical Program for PKM-01, for Local Treatment of Gout Flares, Directly by a Phase 2 Trial

Retrieved on: 
Monday, February 26, 2024
Research, FDA, Clinical Trials, Stem Cells, Biotechnology, Managed Care, Health, Pharmaceutical, Science, Toxicity, Arthritis, Ankle, Diet, Inflammation, Obesity, Ageing, Food, Pain, News, Gout, Colchicine, Doctor of Philosophy, Prevalence, Safety, Rheumatology, Joint, Haematopoietic system, Contraindication, Patient, Knee, Ropivacaine, Pharmaceutical industry

During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.

Key Points: 
  • During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.
  • PKM-01 is a local intra-articular injection treatment for gout flares, developed by PK MED, aiming to provide a fast an effective pain relief and powerful and safe anti-inflammatory effect.
  • Thanks to its low-risk toxicity profile, PKM-01's clinical program will start directly in phase 2, which should considerably speed up time-to-market.
  • PK MED is now entering the fund-raising phase to finance PKM-01 phase 2 clinical trials.

Introducing SYNSYS Microprocessor Full-Leg System, an Entirely New Angle

Retrieved on: 
Wednesday, March 6, 2024
Motion, Ankle, Quality of life, Foot, Life, Risk, Requena, Amputation, Walking, PDAC, Knee, Patient, Heel, Jelly shoes, Hip, Sports equipment

TEMPE, Ariz., March 6, 2024 /PRNewswire/ -- PROTEOR announced the US launch of the PDAC verified SYNSYS microprocessor full-leg system, an entirely new angle on performance for low to moderate K3 activity levels. Previously only available in Europe, SYNSYS offers US clinicians and amputees an entirely new angle on:

Key Points: 
  • Only SYNSYS microprocessor full-leg system offers triple flexion movements allowing a synergistic interaction between the hip, knee, and ankle.
  • TEMPE, Ariz., March 6, 2024 /PRNewswire/ -- PROTEOR announced the US launch of the PDAC verified SYNSYS microprocessor full-leg system, an entirely new angle on performance for low to moderate K3 activity levels.
  • SYNSYS provides greater confidence with more shoe options than any other prosthesis available, longer battery life (up to 10 days), and ease while walking.
  • Sparking inspiration with innovation, SYNSYS offers clinicians and amputees an entirely new angle on motion, stability, and life.